tirzepatide for weight loss vs semaglutide The infographic compares 10 commonly

Log in This article is exclusive to STAT+ subscribers Unlock this article plus daily intelligence on Capitol Hill and the life sciences industry by subscribing to STAT+

These three incretin peptides dominate weight-loss research, but they are not equal

Currently, no published clinical trials have specifically examined tirzepatide's effects on cognitive function or Alzheimer's disease progression in humans

Its established track record and immediate availability make it the practical choice for most patients

Payers hesitation to cover GLP-1s for weight loss is also fueled by employer plan sponsor concerns about up-front costs of the drugs

Ask your pharmacy about seasonal shipping upgrades that automatically apply during warm months